HR 664
106th Congress
House
Health
Ambulatory care
Commerce
Congress
Congressional reporting requirements
Drug industry
Drugs
Drugstores
Hospices (Terminal care)
Medicare
Prescription pricing
Price discrimination
Social Welfare
Terminally ill
Prescription Drug Fairness for Seniors Act of 1999
Introduced: February 10, 1999
See on congress.gov
Everywhere this bill has been
11 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 17, 2000
Sponsor introductory remarks on measure. (CR H6099-6102)
Jun 19, 2000
Sponsor introductory remarks on measure. (CR H4659-4661, H4661-4662)
Feb 15, 2000
Sponsor introductory remarks on measure. (CR H418-419, H425)
Sep 27, 1999
Sponsor introductory remarks on measure. (CR H8831)
Sep 22, 1999
Sponsor introductory remarks on measure. (CR H8540-8546)
May 19, 1999
Sponsor introductory remarks on measure. (CR H3363-3370)
Mar 11, 1999
Referred to the Subcommittee on Health and Environment.
Feb 22, 1999
Referred to the Subcommittee on Health.
Feb 11, 1999
Sponsor introductory remarks on measure. (CR H628, H631)
Feb 10, 1999
Referred to the Committee on Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Feb 10, 1999
Introduced in House
Plain-English summary
Prescription Drug Fairness for Seniors Act of 1999 - Requires each participating manufacturer of a covered outpatient drug to make available for purchase by each pharmacy such covered outpatient drug in the described amount (an amount equal to the aggregate amount of the covered outpatient drug sold or distributed by the pharmacy to Medicare beneficiaries) and at the described price (the price equal to the lower of either the lowest price paid for the drug by the Federal Government or the manufacturer's best price for the drug). Sets forth special provisions with respect to hospice programs.
What's happening now
Sponsor introductory remarks on measure. (CR H6099-6102)
Committees of jurisdiction
4